Citation Impact

Citing Papers

High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells
2005 StandoutScience
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
2005 StandoutNature
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
2002
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
1994
Hallmarks of Cancer: The Next Generation
2011 Standout
Biology of basal cell carcinoma (Part I)
1991
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Biology of basal cell carcinoma (Part II)
1991
Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis
1992
Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites
1988
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma
1999
MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer
2003 Standout
Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer
1994
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
2002 StandoutNobel
Vascular targeting—a new approach to the therapy of solid tumors
1994
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Functional Classification and Experimental Dissection of Long Noncoding RNAs
2018 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
The role of p53 in tumour suppression: lessons from mouse models
1999
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
The Cellular Basis of Site-Specific Tumor Metastasis
1990
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
1995
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
1990
Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinomain situ of the breast
1999
Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
1995
The microenvironment of the tumour–host interface
2001 StandoutNature
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
1995
Clonal Genetic Alterations in the Lungs of Current and Former Smokers
1997
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival
1994
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
The role of vascular endothelial growth factor in pathological angiogenesis
1995
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
1993
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
1996 Standout
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
1998
Mechanisms of Bone Metastasis
2004 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
1995
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
2001 StandoutNobel
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Signal Transduction Pathways Mediated by PECAM-1
2003
Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance Scanner
2007
Life with Oxygen
2007 StandoutScienceNobel
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
2000
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment
2000
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.
1995
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Estrogen and Angiogenesis
2001
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
1998
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells.
1996
Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
1987
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
PECAM-1/CD31 Trans-homophilic Binding at the Intercellular Junctions Is Independent of Its Cytoplasmic Domain; Evidence for Heterophilic Interaction with Integrin αvβ3 in Cis
2000
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
1993
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
1994
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1993
Angiogenesis in Endocrine Tumors
2003
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Geometric Control of Cell Life and Death
1997 StandoutScience
Surface molecular recognition
2001 StandoutNobel
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004

Works of E Horak being referenced

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
1991
Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer.
1993
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
1992
Analysis of Organ-Specific Effects on Metastatic Tumor Formation by Studies In Vitro<xref ref-type="fn" rid="FN1">2</xref>
1986
Intercellular junctions of methylcholanthrene-induced rat skin basocellular and squamous carcinomas
1984
Rankless by CCL
2026